Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Yidu TechHKSE:02158 -1.19%72 Quick Ratio is 4.80 as of Mar. 2026, which is 29% below its 10-year median of 6.72. GuruFocus rates HKSE:02158 with a GF Score™ of 72/100 and a GF Value™ of HK$6.13 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 681 Healthcare Providers & Services companies, Yidu Tech ranks better than 88.4% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Yidu Tech's quick ratio for the quarter that ended in Mar. 2026 was 4.80.
Yidu Tech has a quick ratio of 4.80. It generally indicates good short-term financial strength.
The historical rank and industry rank for Yidu Tech's Quick Ratio or its related term are showing as below:
HKSE:02158'
s Quick Ratio Range Over the Past 10 Years
Min: 0.32 Med: 6.72 Max: 12.35
Current: 4.8
During the past 9 years, Yidu Tech's highest Quick Ratio was 12.35. The lowest was 0.32. And the median was 6.72.
HKSE:02158's Quick Ratio is ranked better than 88.4% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 1.3
vs HKSE:02158: 4.80
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Yidu Tech Quick Ratio Related Terms
Yidu Tech Quick Ratio Historical Data
* Premium members only.
The historical data trend for Yidu Tech's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02158 vs VEEV, BTSG, HQY: Quick Ratio Comparison
For the Health Information Services subindustry, Yidu Tech's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yidu Tech Quick Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Yidu Tech's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Yidu Tech's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Yidu Tech's Quick Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yidu Tech (HKSE:02158) has a Quick Ratio of 4.80 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Yidu Tech and its competitors. This is 29% below median its historical median of 6.72. Over the past decade, Yidu Tech's Quick Ratio has ranged from 0.32 to 12.35. According to the industry distribution chart, Yidu Tech ranks #79 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 11.6%.
Is Yidu Tech's Quick Ratio too high?
Yidu Tech's current Quick Ratio of 4.80 is 29% below median its 10-year median of 6.72. Over the past 10 years, this metric has ranged from a low of 0.32 to a high of 12.35. The Healthcare Providers & Services industry median Quick Ratio is 1.30. Yidu Tech's value of 4.80 is 269.2% above this industry median. Based on the distribution chart, Yidu Tech ranks #79 out of 681 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Yidu Tech has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Yidu Tech's Quick Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Yidu Tech ranks #79 out of 681 companies for Quick Ratio. This places Yidu Tech in the top 12% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.30. Yidu Tech's value of 4.80 is 269.2% above this benchmark. Historically, Yidu Tech's own Quick Ratio has ranged from 0.32 to 12.35 over the past decade. While the company's 10-year median is 6.72 vs. the industry median of 1.30, Yidu Tech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Healthcare Providers & Services company?
The median Quick Ratio among Healthcare Providers & Services companies is 1.30, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yidu Tech's current Quick Ratio of 4.80 is 269.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Yidu Tech and its competitors. For the Healthcare Providers & Services industry, the median Quick Ratio is 1.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yidu Tech's current Quick Ratio is 4.80, which is 29% below median its own 10-year median of 6.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yidu Tech stock overvalued right now?
Based on GuruFocus' analysis, Yidu Tech (HKSE:02158) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$6.13, compared to a current price of HK$4.57 — trading 25.4% below its estimated fair value. The current Quick Ratio is 4.80, which is 29% below median its 10-year median of 6.72 and 269.2% above the Healthcare Providers & Services industry median of 1.30. Yidu Tech's overall GF Score™ is 72/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Yidu Tech (HKSE:02158), the current Quick Ratio is 4.80 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Yidu Tech (HKSE:02158) Overvalued in 2026?
Based on GuruFocus' analysis, Yidu Tech stock appears to be undervalued.
The current stock price of HK$4.57 is trading 25.4% below its estimated GF Value™ of HK$6.13.
GuruFocus considers Yidu Tech to be Modestly Undervalued.
Key valuation signals for HKSE:02158:
Quick Ratio: 4.80 (29% below median its 10-year median of 6.72)
GF Value™: HK$6.13 vs. price of HK$4.57 (25.4% below fair value)
Industry Position: 269.2% above the Healthcare Providers & Services median (#79 of 681)
No single metric tells the full story. See the HKSE:02158 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Yidu Tech Inc offers healthcare solutions built on big data and artificial intelligence (AI) technologies. The company serves various healthcare industry participants, including hospitals, pharmaceutical, biotech, research institutions, insurance companies, etc. Its operating segments are: Big data platform and solutions, Life sciences solutions, and Health management platform and solutions. The majority of the company's revenue is generated from its Big data platform and solutions segment, which provides data intelligence platforms and data analytics-driven solutions (such as Eywa 5.0, Lingxi Intelligent Management, AI Middleware, etc.) for hospitals, healthcare institutions, regulators, and policymakers. Geographically, the company generates maximum revenue from Mainland China.
72GF Score
Get the complete analysis for HKSE:02158
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02158 has been successfully added to your 
